Therefore, UNC119B was expected to be a novel therapeutic target for HCC, and further exploration of UNC119B in HCC might reveal the mechanism of immunotherapy and chemotherapy resistance. This evidence concerns the gene UNC119B and hepatocellular carcinoma.